Business29 Aralık 2025Royalty Pharma, Evrysdi’nin kalan telif hakkını 240 milyon dolara satın aldıSOURCE:Investing Türkiye|BY:Investing.comFailed to fetch content: Request failed with error code 403Share:Read Original Article →